CD274 and neoplasm: PD-1, an immunoregulatory checkpoint receptor expressed on activated T cells, including tumor-infiltrating lymphocytes, plays a pivotal role in immune evasion when it interacts with its ligands, PD-L1 and PD-L2, resulting in the suppression of cytotoxic T cell responses (10–13).